PillRx only · Injection · Intramuscular
Furosemide
Furosemide
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers6 labelers
Packages17
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.372
Latest avg · Jun 17, 2026
+67%
Since Jul 23, 2025
6
Active US suppliers
47%
Top-2 supplier share*
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hikma Pharmaceuticals USA Inc. | unknown | 5 | SUPPLYING |
| Accord Healthcare Inc. | unknown | 3 | SUPPLYING |
| Micro Labs Limited | unknown | 3 | SUPPLYING |
| Amneal Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
| Medical Purchasing Solutions, LLC | unknown | 2 | SUPPLYING |
| Civica, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.